Related Experiment Videos
Feeding intolerance following ophthalmologic examination.
American Journal of Diseases of Children (1960)
|April 1, 1985
Summary
Ophthalmologic examinations in newborns using mydriatic eye drops may increase the risk of feeding intolerance. Researchers observed increased abdominal distention and gastric issues post-examination in neonates.
Area of Science:
- Neonatal Medicine
- Ophthalmology
- Pediatric Gastroenterology
Background:
- Necrotizing enterocolitis (NEC) has been anecdotally linked to mydriatic medications used in ophthalmologic exams.
- Mydriatic agents like cyclopentolate hydrochloride and phenylephrine hydrochloride are commonly used in neonatal eye exams.
Purpose of the Study:
- To investigate the incidence of feeding difficulties in newborns before and after ophthalmologic examinations.
- To assess the potential association between mydriatic eye drops, ophthalmologic procedures, and neonatal feeding intolerance.
Main Methods:
- A comparative study of 50 newborns undergoing ophthalmologic examinations.
- Review of nursing notes to quantify feeding difficulties, including abdominal distention and gastric aspirates, within 24 hours pre- and post-examination.
- All infants received cyclopentolate hydrochloride and phenylephrine hydrochloride prior to examination.
Main Results:
- A significant increase in abdominal distention and gastric aspirates was noted in the 24-hour period following the ophthalmologic examination compared to the pre-examination period.
- One infant developed necrotizing enterocolitis (NEC) within the 24-hour post-examination period.
- Feeding intolerance was more prevalent after the examination.
Conclusions:
- Ophthalmologic examinations in neonates, particularly those involving mydriatic medications, pose a risk of feeding intolerance.
- Potential contributing factors include the known side effects of mydriatic drugs and the physical stress of the examination.
- Neonatal feeding intolerance following eye exams warrants careful monitoring and consideration of medication and procedural impacts.